Land: Irland
Språk: engelsk
Kilde: HPRA (Health Products Regulatory Authority)
Procaine benzylpenicillin; Dihydrostreptomycin sulphate
Franklin Pharmaceuticals Ltd.
QJ01RA
Procaine benzylpenicillin; Dihydrostreptomycin sulphate
200, 200 milligram(s)/millilitre
Suspension for injection
POM: Prescription Only Medicine as defined in relevant national legislation
Cattle
Combinations of antibacterials
Antibacterial
Authorised
1987-10-01
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Megapen - Strep Injection. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 3 PHARMACEUTICAL FORM Suspension for injection. A white aqueous solution 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Bovine. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For the treatment and control of infections caused by bacteria sensitive to procaine penicillin or dihydrostreptomycin sulphate. 4.3 CONTRAINDICATIONS Do not use in cases of known hypersensitivity to the active ingredients. Do not administer by the intravenous route. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None known. Each ml contains: Active substances Procaine Benzylpenicillin 200 mg Dihydrostreptomycin Sulphate 200 mg Excipient Methyl Parahydroxybenzoate 1.0 mg Sodium Formaldehyde Sulfoxylate 1.48 mg For a full list of excipients, see section 6.1 I R I S H M E D I C I N E S B O A R D ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ _D_ _a_ _t_ _e_ _ _ _P_ _r_ _i_ _n_ _t_ _e_ _d_ _ _ _2_ _8_ _/_ _0_ _4_ _/_ _2_ _0_ _1_ _1_ _C_ _R_ _N_ _ _ _7_ _0_ _1_ _0_ _6_ _2_ _0_ _p_ _a_ _g_ _e_ _ _ _n_ _u_ _m_ _b_ _e_ _r_ _:_ _ _ _1_ 4.5 SPECIAL PRECAUTIONS FOR USE SPECIAL PRECAUTIONS FOR USE IN ANIMALS Use of the product should be based on susceptibility testing of the bacteria isolated from the animal. If this is not possible, therapy should be based on local (regional, farm level) epidemiological information about susceptibility of the target bacteria. SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE VETERINARY MEDICINAL PRODUCT TO ANIMALS Avoid direct contact with p read_full_document